1. A review of applying transarterial chemoembolization (TACE) method for management of hepatocellular carcinoma
   Mahyar Mohammadifard et al, 2021, Journal of Family Medicine and Primary Care CrossRef
2. Doxorubicin-induced Cardiotoxicity and Cardioprotective Agents: Classic and New Players in the Game
   Felipe dos Santos Arruda et al, 2019, Current Pharmaceutical Design CrossRef
3. Current management of hepatocellular carcinoma: An Eastern perspective
   Hyung Joon Yim, 2015, World Journal of Gastroenterology CrossRef
4. Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model
   Sibu P. Kuruvilla et al, 2017, PLOS ONE CrossRef
5. A novel cell cycle blocker extracted from Stellera chamaejasme L. inhibits the proliferation of hepatocarcinoma cells
   XIAO-XI KAN et al, 2016, Oncology Reports CrossRef
6. Complete response induced by hepatic arterial infusion chemotherapy in large advanced hepatocellular carcinoma invading the right atrium
   Riho Fukuda et al, 2023, Kanzo CrossRef
7. Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma
   Wan-Jiang Xue et al, 2016, Scientific Reports CrossRef
8. Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West
   Yi-Hao Yen et al, 2020, PLOS ONE CrossRef
9. Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis
   Zan Shen et al, 2016, Molecular Therapy CrossRef
10. Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class A
    Beom-Hui Lee et al, 2019, World Journal of Surgical Oncology CrossRef
11. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis
    Bao-Jiang Liu et al, 2021, BioMed Research International CrossRef
12. Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma – systematic review and meta‐analysis
    Kenya Yamanaka et al, 2013, Cancer Medicine CrossRef
13. Hepatic arterial infusion chemotherapy combined with sorafenib versus sorafenib alone for advanced hepatocellular carcinoma: a systematic review and meta-analysis
    Shunyu Kong et al, 2023, Clinical Journal of Gastroenterology CrossRef
14. Smh-3 induces G2/M arrest and apoptosis through calcium-mediated endoplasmic reticulum stress and mitochondrial signaling in human hepatocellular carcinoma Hep3B cells
    CHIN-YU LIU et al, 2013, Oncology Reports CrossRef
15. Hepatic arterial infusion in hepatocellular carcinoma: a single center experience
    Bohuslav Melichar et al, 2015, Biomedical Papers CrossRef
16. Clinical study on the sensitivity test guided hepato-arterial/portal-vein chemotherapy in patients with unresectable hepatocellar carcinoma
    Dongde Wu et al, 2014, International Journal of Cancer Therapy and Oncology CrossRef
17. Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west
    Jian Lu et al, 2019, The Lancet Gastroenterology & Hepatology CrossRef
18. Berberine and S allyl cysteine mediated amelioration of DEN+CCl4 induced hepatocarcinoma
    Dipanwita Sengupta et al, 2014, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
19. Multimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma
    Chihwan Choi et al, 2014, Liver Cancer CrossRef
20. Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis
    Shun Kaneko et al, 2020, Hepatology Research CrossRef